UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 25, 2011 (May 24, 2011)
KMG Chemicals, Inc.
(Exact name of registrant as specified in its charter)
| TEXAS | 000-29278 | 75-2640529 | ||
| (State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| 9555 W. Sam Houston Pkwy S,
Suite 402, Houston, Texas |
77099 | |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: 713-600-3800
| (Former name or former address if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02(d) Departure of Directors or
Principal Officers; Election of Directors; Appointment of Principal
Officers
On May 24, 2011, the Board of Directors of
KMG Chemicals, Inc., voted to add John C. Hunter, III to the Board of
Directors. His term will expire at the Annual Stockholders Meeting in 2011.
There are no understandings or arrangements between Mr. Hunter and any
other person by which he was selected as a director. Mr. Hunter was
appointed to the Nominating and Governance Committee.
A copy of the Press Release issued by the Company on May 25, 2011 is included as Exhibit 99.1 to this report on Form 8-K.
Item 9.01 Financial Statements and Exhibits
|
Exhibit Number
|
Exhibit | |
|
|
||
|
99.1
|
Press Release dated May 25, 2011 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
KMG Chemicals, Inc.
By: /s/ John V. Sobchak
Date: May 25, 2011
John V. Sobchak,
Chief Financial Officer